
Life Sciences
BridgeBio to Present Phase 3 Encaleret Data at Boston Bone Meeting
The company's results in autosomal dominant hypocalcemia type 1 are scheduled for two oral presentations on October 11 at the Boston gathering.
Boston Business Watch reported on HypoPARAthyroidism Association on October 7, 2026.
October 7, 2026
Posters set for October 10 cover symptom burden at baseline and, with the HypoPARAthyroidism Association, a regional model offering free genetic testing and counseling to relatives of diagnosed patients.

Life Sciences
The company's results in autosomal dominant hypocalcemia type 1 are scheduled for two oral presentations on October 11 at the Boston gathering.